Dogwood Therapeutics
DWTX
24 hedge funds and large institutions have $212K invested in Dogwood Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
989% more capital inflows, than outflows
Capital inflows: $116K | Capital outflows: $10.6K
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
14% more funds holding
Funds holding: 21 → 24 (+3)
0.03% less ownership
Funds ownership: 3.58% → 3.55% (-0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$52.5K |
| 2 |
HRT Financial
New York
|
+$19.9K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
+$14.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.7K |
| 5 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$5.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$8.14K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$2.35K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$69 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$64 |
DWTX Hedge Fund Activity: Q2 2024 in Review
24 of the 6,944 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2024, worth a combined $212K — down 36% from $331K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DWTX positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $52.5K. The largest seller was Jane Street, exiting entirely with an estimated $8.14K sold.
- 24 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2024, up from 21 in Q1 2024.
- Funds reported $212K of Dogwood Therapeutics stock for Q2 2024, down 36% quarter-over-quarter.
- 7 funds opened new Dogwood Therapeutics positions in Q2 2024 and 2 closed out, a net change of +5 holders.
- The largest Dogwood Therapeutics buyer in Q2 2024 was UBS Group, an estimated $52.5K added.
- The largest Dogwood Therapeutics seller in Q2 2024 was Jane Street, an estimated $8.14K sold.
Based on aggregated 13F filings for Q2 2024.